| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
141,706 |
123,593 |
$65.43M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,174 |
30,926 |
$1.55M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,772 |
9,642 |
$541K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,432 |
7,077 |
$359K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,499 |
7,131 |
$152K |
| D1206 |
Topical application of fluoride varnish |
8,356 |
8,253 |
$146K |
| D0120 |
Periodic oral evaluation - established patient |
5,227 |
5,203 |
$145K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,564 |
1,463 |
$122K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,523 |
1,394 |
$119K |
| D0140 |
Limited oral evaluation - problem focused |
4,731 |
4,606 |
$119K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,183 |
1,931 |
$113K |
| D1120 |
Prophylaxis - child |
4,680 |
4,667 |
$108K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,622 |
2,543 |
$86K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,170 |
1,056 |
$85K |
| D1351 |
Sealant - per tooth |
6,471 |
1,454 |
$85K |
| D8080 |
Comprehensive orthodontic treatment of the adolescent dentition |
234 |
230 |
$83K |
| D0220 |
Intraoral - periapical first radiographic image |
9,012 |
8,779 |
$82K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
2,095 |
2,085 |
$81K |
| D1110 |
Prophylaxis - adult |
1,700 |
1,693 |
$73K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
946 |
669 |
$65K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,941 |
1,749 |
$63K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
752 |
725 |
$62K |
| 99442 |
|
1,502 |
1,399 |
$59K |
| 99441 |
|
2,213 |
2,103 |
$57K |
| D0330 |
Panoramic radiographic image |
1,421 |
1,414 |
$44K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
532 |
509 |
$41K |
| D9230 |
Inhalation of nitrous oxide / analgesia, anxiolysis |
1,704 |
1,582 |
$39K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
648 |
437 |
$35K |
| D0230 |
Intraoral - periapical each additional radiographic image |
13,908 |
3,792 |
$33K |
| D0274 |
Bitewings - four radiographic images |
2,643 |
2,630 |
$32K |
| D0272 |
Bitewings - two radiographic images |
3,050 |
3,038 |
$30K |
| 99443 |
|
630 |
521 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
8,056 |
7,398 |
$26K |
| 90686 |
|
2,539 |
2,413 |
$24K |
| D0240 |
|
1,792 |
1,786 |
$22K |
| 0012A |
|
834 |
822 |
$20K |
| D0191 |
|
1,565 |
1,564 |
$16K |
| 0001A |
|
402 |
400 |
$15K |
| 90670 |
|
1,064 |
972 |
$12K |
| 0002A |
|
308 |
308 |
$12K |
| 0011A |
|
930 |
891 |
$12K |
| 0064A |
|
381 |
360 |
$11K |
| D1999 |
|
790 |
638 |
$11K |
| D0210 |
Intraoral - complete series of radiographic images |
242 |
242 |
$10K |
| 99215 |
Prolong outpt/office vis |
183 |
145 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
823 |
795 |
$9K |
| 80053 |
Comprehensive metabolic panel |
1,293 |
1,205 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
303 |
293 |
$9K |
| 82610 |
|
734 |
711 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,615 |
1,505 |
$9K |
| 0071A |
|
229 |
221 |
$9K |
| 0072A |
|
139 |
133 |
$5K |
| D7140 |
Extraction, erupted tooth or exposed root |
131 |
62 |
$5K |
| 90651 |
|
467 |
444 |
$5K |
| 98926 |
|
200 |
163 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
322 |
309 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
253 |
239 |
$4K |
| D0270 |
|
667 |
662 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
536 |
500 |
$3K |
| D1354 |
|
958 |
238 |
$3K |
| 92551 |
|
431 |
418 |
$3K |
| D8670 |
Periodic orthodontic treatment visit |
88 |
86 |
$2K |
| 91322 |
|
27 |
27 |
$2K |
| 82570 |
|
500 |
428 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
255 |
218 |
$2K |
| 90677 |
|
104 |
104 |
$2K |
| 90633 |
|
280 |
261 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
41 |
38 |
$2K |
| 90715 |
|
199 |
190 |
$2K |
| D0160 |
|
48 |
48 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
128 |
63 |
$2K |
| 90688 |
|
177 |
167 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
112 |
102 |
$1K |
| 90656 |
|
184 |
181 |
$1K |
| 90734 |
|
159 |
148 |
$1K |
| 99001 |
|
67 |
65 |
$1K |
| 80061 |
Lipid panel |
132 |
114 |
$1K |
| 90710 |
|
100 |
96 |
$1K |
| 90696 |
|
95 |
90 |
$1K |
| 90685 |
|
132 |
112 |
$1K |
| 90619 |
|
145 |
142 |
$1K |
| 96127 |
|
118 |
112 |
$1K |
| 82607 |
|
76 |
62 |
$987.37 |
| D0190 |
|
92 |
92 |
$907.80 |
| 83721 |
|
133 |
115 |
$878.61 |
| 90647 |
|
117 |
105 |
$864.04 |
| 81001 |
|
302 |
273 |
$763.60 |
| 90480 |
|
28 |
28 |
$720.00 |
| 81025 |
|
88 |
86 |
$683.66 |
| 84443 |
Thyroid stimulating hormone (TSH) |
59 |
53 |
$582.28 |
| 90648 |
|
91 |
89 |
$577.18 |
| 90680 |
|
88 |
79 |
$574.23 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
17 |
12 |
$574.05 |
| 98927 |
|
15 |
14 |
$506.70 |
| 98925 |
|
31 |
24 |
$495.16 |
| 90698 |
|
71 |
67 |
$472.36 |
| 0134A |
|
16 |
15 |
$441.63 |
| 90672 |
|
54 |
52 |
$434.46 |
| 99177 |
|
138 |
131 |
$369.62 |
| 90723 |
|
57 |
56 |
$352.20 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$351.23 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$351.23 |
| 84439 |
|
43 |
36 |
$312.21 |
| 98966 |
|
14 |
14 |
$253.12 |
| 84146 |
|
15 |
13 |
$231.36 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
13 |
$200.20 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
87 |
76 |
$195.64 |
| 90707 |
|
16 |
15 |
$193.28 |
| 90716 |
|
13 |
12 |
$167.63 |
| 87210 |
|
39 |
36 |
$159.67 |
| D9630 |
|
25 |
25 |
$140.00 |
| 90681 |
|
16 |
16 |
$83.44 |
| 85027 |
|
13 |
13 |
$81.64 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
17 |
17 |
$77.60 |
| 91301 |
|
1,735 |
1,700 |
$0.00 |
| 91307 |
|
491 |
465 |
$0.00 |
| 91306 |
|
377 |
357 |
$0.00 |
| 91305 |
|
89 |
80 |
$0.00 |
| D1353 |
|
63 |
26 |
$0.00 |
| D9992 |
|
12 |
12 |
$0.00 |
| D4355 |
|
14 |
14 |
$0.00 |
| 91300 |
|
1,034 |
1,021 |
$0.00 |
| D0350 |
|
16 |
16 |
$0.00 |
| 91313 |
|
16 |
15 |
$0.00 |